Clinical research最新文献

筛选
英文 中文
Steroid-Sensitive Encephalopathy Associated With Autoimmune Thyroiditis (SREAT): Case Report 类固醇敏感性脑病与自身免疫性甲状腺炎(great):病例报告
Clinical research Pub Date : 2023-08-05 DOI: 10.35702/clinres.10017
Diego Nicolas Guacaneme, Claudio Alejando Jiménez Monsalve, Orlando Oliveros Pasión, Julieth Milena Rodríguez López, Neiry María Zapa Pérez, Hellen Kreinter, Nelly Daniela Gonzalez Galvis
{"title":"Steroid-Sensitive Encephalopathy Associated With Autoimmune Thyroiditis (SREAT): Case Report","authors":"Diego Nicolas Guacaneme, Claudio Alejando Jiménez Monsalve, Orlando Oliveros Pasión, Julieth Milena Rodríguez López, Neiry María Zapa Pérez, Hellen Kreinter, Nelly Daniela Gonzalez Galvis","doi":"10.35702/clinres.10017","DOIUrl":"https://doi.org/10.35702/clinres.10017","url":null,"abstract":"Background: Steroid-responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) is a rare, controversial and underdiagnosed entity characterized by an acute or subacute onset of encephalopathy. It is a diagnosis of exclusion with supporting criteria that include high titers of anti-thyroid antibodies, a history of Hashimoto's thyroiditis, and a good response to steroids. Case report: An 18-year-old female patient with hypothyroidism and episode of change in behavior, hallucinations and episodes of generalized tonic-clonic movements, normal skull tomography, cerebrospinal fluid with pleocytosis without signs of infection and positive anti-thyroid antibodies with adequate response to management with steroids Conclusion: We considered SERAT as an entity that needs to be rediscovered as it has conflicting results that question if it is a syndrome or a myth. The literature is especially lacking in Colombia where there are not many published cases.","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136083583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Silico Discovery and ADMET Pharmacokinetic of Novel Pyrimidinic Selenoureas as Selective Breast Carcinoma Cells (MCF-7) Inhibitors 新型嘧啶型硒脲作为选择性乳腺癌细胞(MCF-7)抑制剂的硅片发现和ADMET药代动力学研究
Clinical research Pub Date : 2023-08-01 DOI: 10.35702/clinres.10016
Yusuf Isyaku, Adamu Uzairu, Aliyu Muhammad Ja'o
{"title":"In Silico Discovery and ADMET Pharmacokinetic of Novel Pyrimidinic Selenoureas as Selective Breast Carcinoma Cells (MCF-7) Inhibitors","authors":"Yusuf Isyaku, Adamu Uzairu, Aliyu Muhammad Ja'o","doi":"10.35702/clinres.10016","DOIUrl":"https://doi.org/10.35702/clinres.10016","url":null,"abstract":"Pyrimidine is one of aromatic heterocyclic class of organic compounds that’s similar to pyridine. It’s found in the nucleic acids DNA and RNA. Novel pyrimidinic selenoureas were reported to have a remarkable inhibitory activity against breast carcinoma cells (MCF-7). With the help of computer-aided drug design techniques one of these of compounds was further optimized to design three other derivatives with more potency than the previous and also more potent than many anti-breast cancer drugs. The main aim of this study was to design more potent pyrimidinic selenoureas derivatives and compare them with the standard anti-breast cancer drugs. An optimization method of structure-based drug design was employed. Two compounds of novel pyrimidinic selenoureas were reported in which the first compound was selected and docked with the ERBB2 receptor tyrosine kinase (PDB ID: 2A91), it was then modified to design three (3) derivatives. The receptors were later docked with seven (7) different anti-breast cancer drugs approved by American Cancer Society (such as, Capecitabine, Cisplatin, Curcumin, Paclitaxel, Ixabepilone, Doxorubicin and Vinorelbine) to record their potency and later compared with the designed compounds. An ADMET pharmacokinetic study was carried out on the designed compounds to investigate their drug-likeness. In the result, all the designed compounds were found to be more potent than the template, in which compound a1 and a2 (with moldock score of -148.456 and -153.725) were found to be more potent than Capecitabine, Cisplatin, Curcumin, Doxorubicin and Vinorelbine (moldock score; -134.953, -43.889, -148.290, -106.187 and -134.986), but less active than Paclitaxel and Ixabepilone (with moldock scores of -154.135 and -157.093), with compound a3 (moldock score; -161.583) recorded the highest potency which is more potent than all the listed drugs, and also the designed compounds were found to have good pharmacokinetic profiles. Conclusively, three other derivatives of novel pyrimidinic selenoureas were designed and found to be more potent than the template and many anti-breast cancer drugs. The compounds should be further synthesized for their excellent activities and good pharmacokinetic parameters.","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135005110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical aspects of dementia research: informed consent and proxy consent. 痴呆研究的伦理方面:知情同意和代理同意。
Clinical research Pub Date : 1994-10-01
G A Sachs, C B Stocking, R Stern, D M Cox, G Hougham, R S Sachs
{"title":"Ethical aspects of dementia research: informed consent and proxy consent.","authors":"G A Sachs, C B Stocking, R Stern, D M Cox, G Hougham, R S Sachs","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"42 3","pages":"403-12"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18951625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer risk research: what should we tell subjects? 癌症风险研究:我们应该告诉受试者什么?
Clinical research Pub Date : 1994-10-01
E Kodish, T H Murray, S Shurin
{"title":"Cancer risk research: what should we tell subjects?","authors":"E Kodish, T H Murray, S Shurin","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"42 3","pages":"396-402"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18951624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1994 Clinical Research Meeting. Baltimore, Maryland, April 29-May 2, 1994. Abstracts. 1994临床研究会议。1994年4月29日至5月2日,马里兰州巴尔的摩。摘要。
Clinical research Pub Date : 1994-04-01
{"title":"1994 Clinical Research Meeting. Baltimore, Maryland, April 29-May 2, 1994. Abstracts.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"42 2","pages":"177-383"},"PeriodicalIF":0.0,"publicationDate":"1994-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19177452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The First Lady addresses the NIH. February 17, 1994. 第一夫人在国家卫生研究院发表演讲。1994年2月17日。
Clinical research Pub Date : 1994-04-01
H Rodham Clinton
{"title":"The First Lady addresses the NIH. February 17, 1994.","authors":"H Rodham Clinton","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"42 2","pages":"156-60"},"PeriodicalIF":0.0,"publicationDate":"1994-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19177451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ethical conduct of health services research: a case study of 55 institutions' applications to the SUPPORT project. 卫生服务研究的道德行为:对55个机构申请支助项目的个案研究。
Clinical research Pub Date : 1994-02-01
J Lynn, J Johnson, R J Levine
{"title":"The ethical conduct of health services research: a case study of 55 institutions' applications to the SUPPORT project.","authors":"J Lynn, J Johnson, R J Levine","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"42 1","pages":"3-10"},"PeriodicalIF":0.0,"publicationDate":"1994-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19189865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of DNR orders on CPR research: educational and ethical implications. 急救令对心肺复苏术研究的影响:教育和伦理意义。
Clinical research Pub Date : 1993-12-01
J P Orlowski
{"title":"The impact of DNR orders on CPR research: educational and ethical implications.","authors":"J P Orlowski","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"41 4","pages":"595-600"},"PeriodicalIF":0.0,"publicationDate":"1993-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19104292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Problems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation. 风险治疗试验中停止规则的问题:华法林预防房颤中风的案例。
Clinical research Pub Date : 1993-10-01
D E Singer
{"title":"Problems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation.","authors":"D E Singer","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"41 3","pages":"482-6"},"PeriodicalIF":0.0,"publicationDate":"1993-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19389301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scientists, societies, and science education. 科学家、社会和科学教育。
Clinical research Pub Date : 1993-04-01
M Fordis
{"title":"Scientists, societies, and science education.","authors":"M Fordis","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10429,"journal":{"name":"Clinical research","volume":"41 2","pages":"165-78"},"PeriodicalIF":0.0,"publicationDate":"1993-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19460936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信